Low molecular weight heparin can prevent progression of isolated calf muscle vein thrombosis

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1318, 2001-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of a Low-Molecular-Weight Heparin in Prolonged Prophylaxis Against Deep Vein Thrombosis After Total Hip Replacement

By Detournay B.

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 81-89

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Desirudin Compared with a Low Molecular Weight Heparin in the Prevention of Deep Vein Thrombosis after Total Hip Replacement Surgery

By Levin L-å.

PharmacoEconomics, Vol. 19, Iss. 5, 2001-01 ,pp. : 589-597

Adis International

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin Prophylaxis of Deep Vein Thrombosis for Older Patients with Restricted Mobility: Propensity Analyses of Data from Two Multicentre, Cross-Sectional Studies

By Labarère José Sevestre Marie-Antoinette Belmin Joël

Drugs & Aging, Vol. 26, Iss. 3, 2009-01 ,pp. : 263-271

Adis International

Access to resources Recommend Favorite

Heparin/low molecular weight heparins: Fatal heparin-induced thrombocytopenia and thrombosis syndrome in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1231, 2008-01 ,pp. : 16-17

Adis International

Access to resources Recommend Favorite

Development of PEG-PLGA based Intravenous Low Molecular Weight Heparin (LMWH) Nanoparticles Intended to Treat Venous Thrombosis

Current Drug Delivery, Vol. 13, Iss. 5, 2016-08 ,pp. : 698-710

Bentham Science Publishers

Access to resources Recommend Favorite